Top Stories: Page 168

Create a Winning License Application: 15 Tips

If you’re serious about obtaining a license to cultivate, process and/or distribute cannabis, pay attention to what these five industry experts have to say.

Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research

The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.

Appeals Court Rules that New Jersey Company Must Cover Employee’s Medical Cannabis Costs

With worker’s compensation ordered to cover medical cannabis, will private insurers follow suit in New Jersey and beyond?

How to Expand Your Greenhouse Facility to Support Cannabis or Hemp Crops: Q&A with Nadia Sabeh

The founder of Dr. Greenhouse discusses important considerations when making the switch from growing traditional greenhouse crops to cannabis or hemp.

Platinum Confronts Counterfeit Products in Michigan, California

The company has worked alongside law enforcement to get illicit products removed from store shelves, and recently launched a QR code solution to help customers verify the authenticity of its products.

New York Governor Renews Push for Cannabis Legalization

Gov. Andrew Cuomo vowed to legalize adult-use cannabis this year during his 2020 State of the State address Jan. 8.

With Alcohol Consumption Down Among Millennials, Big Businesses See Opportunities for THC-Infused Beverages

As companies continue to perfect cannabis-infused beverages, the category could gradually supplant alcohol.

California Governor Proposes Consolidating Three Cannabis Licensing Authorities

Changes also include new tax structures that shift responsibility to retailers.

South Dakota Becomes First State to Place Medical and Adult-Use Cannabis Initiatives on Same Ballot

The Marijuana Policy Project is working with the campaign committees on public education and marketing strategies ahead of the November election.

Newly Discovered Natural Cannabinoid THCP Offers Greater Potency Than THC

Recently published work from an Italian research team describes how THCP may help scientists understand why some cannabis chemovars are more potent than others.

Not So Fast

How antitrust regulators in Washington, D.C., are slowing down cannabis M&A deals—and changing the industry for the better.

Toronto-Based FSD Pharma Begins Trading on NASDAQ

The stock begins trading under the symbol ‘HUGE’ on Jan. 9, placing FSD Pharma in a select group of 12 Canadian-domiciled cannabis companies trading on the NYSE or NASDAQ.

Previous Page

Page 168 of 261

Next Page